(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are POLIGHT, HYLORIS, and FUT.CLUBE PORTO.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| POLIGHT (PLT.OL) | 4.80 | 21.83% | 2024-08-19 12:42:25 |
| HYLORIS (HYL.BR) | 7.00 | 9.72% | 2024-08-19 12:20:10 |
| FUT.CLUBE PORTO (FCP.LS) | 1.22 | 8.93% | 2024-08-19 12:23:19 |
| SEQUANA MEDICAL (SEQUA.BR) | 1.08 | 8.87% | 2024-08-19 12:21:20 |
| EUROCASTLE INVEST. (ECT.AS) | 7.60 | 8.57% | 2024-08-19 12:01:54 |
| WEBSTEP (WSTEP.OL) | 23.30 | 5.91% | 2024-08-19 12:44:30 |
| FORFARMERS (FFARM.AS) | 3.01 | 5.81% | 2024-08-19 12:02:06 |
| BEWI (BEWI.OL) | 28.45 | 5.75% | 2024-08-19 12:25:08 |
| ZAPTEC (ZAP.OL) | 11.08 | 5.02% | 2024-08-19 12:44:43 |
| MULTICONSULT (MULTI.OL) | 168.00 | 5% | 2024-08-19 12:41:17 |
The three biggest losers today are AVANCE GAS HOLDING, ENSURGE MICROPOWER, and NYKODE THERAPEUTIC.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| AVANCE GAS HOLDING (AGAS.OL) | 131.00 | -12.9% | 2024-08-19 12:24:57 |
| ENSURGE MICROPOWER (ENSU.OL) | 1.28 | -11.28% | 2024-08-19 12:25:59 |
| NYKODE THERAPEUTIC (NYKD.OL) | 10.43 | -9.62% | 2024-08-19 12:41:48 |
| TOYOTA CAETANO (SCT.LS) | 5.05 | -9.01% | 2024-08-19 12:24:06 |
| BW LPG (BWLPG.OL) | 159.10 | -5.97% | 2024-08-19 12:25:22 |
| TEKNA HOLDING (TEKNA.OL) | 5.50 | -5.17% | 2024-08-19 12:44:02 |
| ARAMIS GROUP (ARAMI.PA) | 5.22 | -5.09% | 2024-08-19 12:45:55 |
| ABIONYX PHARMA (ABNX.PA) | 1.29 | -5.02% | 2024-08-19 12:44:51 |
| HYDROGENPRO (HYPRO.OL) | 9.50 | -4.81% | 2024-08-19 12:40:31 |
| ADOCIA (ADOC.PA) | 5.67 | -4.55% | 2024-08-19 12:45:11 |
Winners today
1. POLIGHT (PLT.OL)
21.83% Price Change
poLight ASA develops optical lens for consumer devices and industrial applications in Europe, Asia, and the United States. The company's lens replicates the lens of the human eye enabling the implementation of autofocus functions for various applications. Its product portfolio includes TLens, a tuneable optical lens for autofocus camera applications; Packaged TLens that facilitates integration of a TLens on a fixed-focus camera module; driver ASIC is designed to drive capacitive loads such as the TLens autofocus actuators; and evaluation kits that allows to test and evaluate the optical and electrical performance of the TLens in new products and/or applications. It serves smartphones and wearables, industrial, augmented reality, healthcare, and webcams markets. poLight ASA was founded in 2005 and is headquartered in Skoppum, Norway.
Oslo Børs Benchmark Index_GI ended the session with POLIGHT rising 21.83% to €4.80 on Monday while Oslo Børs Benchmark Index_GI jumped 0.4% to €1,448.60.
Earnings Per Share
As for profitability, POLIGHT has a trailing twelve months EPS of kr-1.19.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -56.66%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 82%, now sitting on 16.67M for the twelve trailing months.
Yearly Top and Bottom Value
POLIGHT’s stock is valued at kr4.80 at 22:40 EST, way under its 52-week high of kr25.70 and way higher than its 52-week low of kr2.34.
Volume
Today’s last reported volume for POLIGHT is 3541710 which is 124.39% above its average volume of 1578310.
More news about POLIGHT.
2. HYLORIS (HYL.BR)
9.72% Price Change
BEL 20 ended the session with HYLORIS jumping 9.72% to €7.00 on Monday while BEL 20 rose 0.22% to €4,084.74.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HYLORIS’s stock is considered to be overbought (>=80).
More news about HYLORIS.
3. FUT.CLUBE PORTO (FCP.LS)
8.93% Price Change
Futebol Clube do Porto – Futebol, S.A.D., together with its subsidiaries, participates in professional football competitions, and the sporting events promotion and organization in Portugal. It also engages in the image rights commercialization, sponsoring, merchandising, and products licensing activities; production, editing, and commercialization of multimedia material, as well as Internet, periodical, and non-periodical publications; and sport equipment management and exploration business, as well as insurance broking activities. In addition, the company organizes and sells travel and tour packages; and tickets and seat reservations, as well as represents travel agencies and tourism. Further, it is involved in the concept, design, development, production, direction, promotion, marketing, acquisition, exploration rights, recording, distribution, and dissemination of works and audiovisual programs, multimedia, television, video, cinema, theme, Internet, channels, tourist events, and cultural and sporting in any formats and systems. Additionally, the company manages, operates, and provides services in the areas of recording, production, and communication of audiovisual works, television shows, sounds, images, and other audiovisuals; and edits periodic publicities, books, and multimedia. It also explores for the Porto Canal cable television channel; and produces and executes advertisings, news reports, documentaries, and TV programs in video support. The company was founded in 1893 and is headquartered in Porto, Portugal.
PSI ended the session with FUT.CLUBE PORTO rising 8.93% to €1.22 on Monday while PSI rose 1.02% to €6,723.81.
Earnings Per Share
As for profitability, FUT.CLUBE PORTO has a trailing twelve months EPS of €-2.12.
More news about FUT.CLUBE PORTO.
4. SEQUANA MEDICAL (SEQUA.BR)
8.87% Price Change
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally. The company products pipeline comprises alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body and heart failure. Sequana Medical NV was founded in 2006 and is headquartered in Ghent, Belgium.
BEL 20 ended the session with SEQUANA MEDICAL jumping 8.87% to €1.08 on Monday, following the last session’s downward trend. BEL 20 jumped 0.22% to €4,084.74, following the last session’s downward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, SEQUANA MEDICAL has a trailing twelve months EPS of €-1.22.
Moving Average
SEQUANA MEDICAL’s value is way below its 50-day moving average of €1.23 and way under its 200-day moving average of €2.23.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SEQUANA MEDICAL’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth declined by 28.4%, now sitting on 712.17k for the twelve trailing months.
Volume
Today’s last reported volume for SEQUANA MEDICAL is 30500 which is 29.44% below its average volume of 43227.
More news about SEQUANA MEDICAL.
5. EUROCASTLE INVEST. (ECT.AS)
8.57% Price Change
Eurocastle Investment Limited is a publicly traded closed-ended investment company that focuses on investing in performing and nonperforming loans and other real estate related assets primarily in Italy. The Company is Euro denominated and is listed on Euronext Amsterdam under the symbol “ECT”. Eurocastle is managed by an affiliate of Fortress Investment Group LLC, a leading global investment manager. For more information regarding Eurocastle Investment Limited and to be added to our email distribution list, please visit www.eurocastleinv.com.
AEX-Index ended the session with EUROCASTLE INVEST. jumping 8.57% to €7.60 on Monday while AEX-Index jumped 0.35% to €908.85.
Earnings Per Share
As for profitability, EUROCASTLE INVEST. has a trailing twelve months EPS of €-0.38.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.88%.
More news about EUROCASTLE INVEST..
6. WEBSTEP (WSTEP.OL)
5.91% Price Change
Webstep ASA provides information technology (IT) consultancy services to public and private businesses in Norway and Sweden. Its services include consulting, digitalization, .Net, Java, open source, full stack, front and back end, user experience, integration, mobility, cloud apps, machine learning, business intelligence, big data, data warehousing, virtual robotics, Devops, application service management, and data science services. The company offers cloud computing, cloud services, sensor technology, product and service development, Beacons, enterprise user experience, web analysis, design team, Amazon Web, Azure, prediction, artificial intelligence, Internet of Things, predictive modelling, workshops, hackathon, business analysis, and search engine optimization services. In addition, it provides project and test management, ISTQB, PMP, Prince 2, ITIL, scrum, delivery projects, CRM, ERP, process management, project management methodology, facilitating, controller, program coordination, contract and offshoring management, and mentoring services, as well as security, cloud infrastructure, and analytics. The company serves banking, finance and insurance, public administration, agriculture and food production, IT and telecommunication, commerce, and transportation industries. The company was founded in 2000 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with WEBSTEP jumping 5.91% to €23.30 on Monday while Oslo Børs Benchmark Index_GI jumped 0.4% to €1,448.60.
Earnings Per Share
As for profitability, WEBSTEP has a trailing twelve months EPS of kr0.06.
PE Ratio
WEBSTEP has a trailing twelve months price to earnings ratio of 388.33. Meaning, the purchaser of the share is investing kr388.33 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.42%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 5.5%, now sitting on 984.71M for the twelve trailing months.
Yearly Top and Bottom Value
WEBSTEP’s stock is valued at kr23.30 at 22:40 EST, way below its 52-week high of kr27.50 and way higher than its 52-week low of kr18.00.
More news about WEBSTEP.
7. FORFARMERS (FFARM.AS)
5.81% Price Change
ForFarmers N.V. provides feed solutions for conventional and organic livestock farming in the Netherlands, Belgium, Germany, Poland, the United Kingdom, other European countries, and internationally. It offers compound feed and blends, feed for young animals and specialties, raw materials and coproducts, seeds, and fertilizers. The company is involved in production and delivery of feed, as well as engaged in logistics services. ForFarmers N.V. was founded in 1896 and is based in Lochem, the Netherlands.
AEX-Index ended the session with FORFARMERS jumping 5.81% to €3.01 on Monday, after two sequential sessions in a row of gains. AEX-Index rose 0.35% to €908.85, following the last session’s downward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, FORFARMERS has a trailing twelve months EPS of €-0.01.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.53%.
Moving Average
FORFARMERS’s worth is above its 50-day moving average of €2.84 and way higher than its 200-day moving average of €2.56.
More news about FORFARMERS.
8. BEWI (BEWI.OL)
5.75% Price Change
BEWi ASA provides packaging, components, and insulation solutions in Norway and internationally. The company operates through RAW, Insulation & Construction (I&C), Packaging & Components (P&C), and Circular segments. The RAW segment produces raw materials, including white and grey expanded polystyrene, and general purpose polystyrene, as well as BioFoam, a bio-based particle foam. The I&C segment develops and manufactures a range of solutions for insulation products for the building and construction industry; and insulation boards from polyisocyanurate and mineral wool sandwich panels. The P&C segment manufactures and sells standard and customised packaging solutions, as well as technical and automotive components for various industrial sectors; and trades products related to food packaging. The Circular segment has a wide offering within waste management; collects and recycles expanded polystyrene; trades used materials; produces recycled general purpose polystyrene; and re-processing of used materials. The company operates through production facilities in Norway, Sweden, Finland, Denmark, Czech Republic, Lithuania, Poland, Germany, Belgium, the Netherlands, Spain, Portugal, and in the United Kingdom; and facilities in Germany, France, Poland. The company was founded in 1980 and is headquartered in Trondheim, Norway. BEWi ASA is a subsidiary of BEWI Invest AS.
Oslo Børs Benchmark Index_GI ended the session with BEWI jumping 5.75% to €28.45 on Monday while Oslo Børs Benchmark Index_GI jumped 0.4% to €1,448.60.
Earnings Per Share
As for profitability, BEWI has a trailing twelve months EPS of kr-1.54.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.23%.
Volume
Today’s last reported volume for BEWI is 397395 which is 458.04% above its average volume of 71212.
More news about BEWI.
9. ZAPTEC (ZAP.OL)
5.02% Price Change
Zaptec ASA engages in the development and sale of chargers, charging systems, and services for electric car charging in Norway, Sweden, Switzerland, Denmark, Iceland, rest of Europe, and internationally. It offers Zaptec Go and Zaptec Pro alternating current walls charging station for indoor and outdoor use; Zaptec Portal, a cloud platform that monitors, balances, and optimizes the load between charging stations, while displaying real-time power usage; and Zaptec Sense for automatically adjusting the charging speed in the buildings. The company also offers accessories, including covers, charging cables, cable holders, RFID tags, and load balancers. Zaptec ASA was incorporated in 2012 and is headquartered in Stavanger, Norway.
Oslo Børs Benchmark Index_GI ended the session with ZAPTEC rising 5.02% to €11.08 on Monday while Oslo Børs Benchmark Index_GI rose 0.4% to €1,448.60.
Earnings Per Share
As for profitability, ZAPTEC has a trailing twelve months EPS of kr0.22.
PE Ratio
ZAPTEC has a trailing twelve months price to earnings ratio of 50.36. Meaning, the purchaser of the share is investing kr50.36 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.79%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ZAPTEC’s stock is considered to be oversold (<=20).
More news about ZAPTEC.
10. MULTICONSULT (MULTI.OL)
5% Price Change
Multiconsult ASA, together with its subsidiaries, engages in the provision of engineering design, consultancy, and architecture services in Norway and internationally. The company offers multidisciplinary consultancy services in the areas, including design, planning, project supervision and management, geotechnical and environmental site surveys, and verification and control; and provides analysis and due diligence, design and construction management, environmental services and HSE, geology and geotechnical study, green bond, hydrometry and hydrological field work, lenders advisory, renewable energy tender, and river basin management services. It serves buildings and properties, cities and society, industry, oil and gas, renewable energy, rail and transportation, and water and environment sectors. The company was founded in 1908 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with MULTICONSULT jumping 5% to €168.00 on Monday while Oslo Børs Benchmark Index_GI jumped 0.4% to €1,448.60.
Earnings Per Share
As for profitability, MULTICONSULT has a trailing twelve months EPS of kr9.33.
PE Ratio
MULTICONSULT has a trailing twelve months price to earnings ratio of 18.01. Meaning, the purchaser of the share is investing kr18.01 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.9%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MULTICONSULT’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for MULTICONSULT is 4596 which is 64.09% below its average volume of 12799.
Moving Average
MULTICONSULT’s value is higher than its 50-day moving average of kr161.87 and way higher than its 200-day moving average of kr141.81.
Volatility
MULTICONSULT’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.88%, a negative 0.25%, and a positive 1.14%.
MULTICONSULT’s highest amplitude of average volatility was 2.08% (last week), 1.53% (last month), and 1.14% (last quarter).
More news about MULTICONSULT.
Losers Today
1. AVANCE GAS HOLDING (AGAS.OL)
-12.9% Price Change
Avance Gas Holding Ltd, together with its subsidiaries, engages in the transportation of liquefied petroleum gas (LPG) worldwide. The company transports LPG from the Middle East Gulf and the United States Gulf/the United States East Coast to destinations in Europe, South America, India, and Asia. As of December 31, 2023, it owned and operated through a fleet of fourteen very large gas carriers and six dual-fuel LPG newbuildings. Avance Gas Holding Ltd was founded in 2007 and is based in Hamilton, Bermuda. Avance Gas Holding Ltd is a subsidiary of Hemen Holding Ltd.
Oslo Børs Benchmark Index_GI ended the session with AVANCE GAS HOLDING dropping 12.9% to €131.00 on Monday while Oslo Børs Benchmark Index_GI jumped 0.4% to €1,448.60.
Earnings Per Share
As for profitability, AVANCE GAS HOLDING has a trailing twelve months EPS of kr38.07.
PE Ratio
AVANCE GAS HOLDING has a trailing twelve months price to earnings ratio of 3.44. Meaning, the purchaser of the share is investing kr3.44 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.24%.
Volume
Today’s last reported volume for AVANCE GAS HOLDING is 564070 which is 287.14% above its average volume of 145701.
More news about AVANCE GAS HOLDING.
2. ENSURGE MICROPOWER (ENSU.OL)
-11.28% Price Change
Ensurge Micropower ASA provides energy storage solutions for wearable devices, connected sensors, and other applications in Norway. The company offers solid-state lithium battery technology that enables it to produce rechargeable batteries. It serves hearables, medical and sports/fitness wearables, and home and industrial devices sectors. The company was formerly known as Thin Film Electronics ASA and changed its name to Ensurge Micropower ASA in June 2021. Ensurge Micropower ASA was incorporated in 2005 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with ENSURGE MICROPOWER falling 11.28% to €1.28 on Monday while Oslo Børs Benchmark Index_GI rose 0.4% to €1,448.60.
Earnings Per Share
As for profitability, ENSURGE MICROPOWER has a trailing twelve months EPS of kr-3.38.
Yearly Top and Bottom Value
ENSURGE MICROPOWER’s stock is valued at kr1.28 at 22:40 EST, way below its 52-week high of kr4.19 and way higher than its 52-week low of kr0.10.
Moving Average
ENSURGE MICROPOWER’s value is way higher than its 50-day moving average of kr0.12 and way above its 200-day moving average of kr0.76.
More news about ENSURGE MICROPOWER.
3. NYKODE THERAPEUTIC (NYKD.OL)
-9.62% Price Change
Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies. The company develops vaccines for the treatment cancer and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of ,melanoma, lung, bladder, renal, head, and neck cancer; VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer; and VB10. COV2, a COVID-19 vaccine candidate covers new SARS-CoV-2 variants. The company has collaboration agreements with Roche, Genentech, MSD, and Nektar Therapeutics; Adaptive Biotechnologies for T cell vaccine development; and research agreement with Regeneron. Nykode Therapeutics AS was founded in 2006 and is based in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with NYKODE THERAPEUTIC dropping 9.62% to €10.43 on Monday, after two sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.4% to €1,448.60, after five sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, NYKODE THERAPEUTIC has a trailing twelve months EPS of kr-1.39.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -25.89%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NYKODE THERAPEUTIC’s stock is considered to be overbought (>=80).
Sales Growth
NYKODE THERAPEUTIC’s sales growth is negative 27% for the ongoing quarter and 102.2% for the next.
Yearly Top and Bottom Value
NYKODE THERAPEUTIC’s stock is valued at kr10.43 at 22:40 EST, under its 52-week low of kr11.48.
Moving Average
NYKODE THERAPEUTIC’s value is way under its 50-day moving average of kr14.04 and way below its 200-day moving average of kr16.09.
More news about NYKODE THERAPEUTIC.
4. TOYOTA CAETANO (SCT.LS)
-9.01% Price Change
Toyota Caetano Portugal, S.A. imports, assembles, and commercializes light and heavy vehicles. It offers commercial and passenger cars, as well as parts; cargo handling machines; and mini-buses. The company also sells and rents industrial equipment, including counterweight forklift trucks and warehouse equipment; provides technical after-sales assistance; incorporates components into commercial vehicles; and offers business services and solutions, such as short-term rental, used and reconditioned assistance, maintenance contracts sale of parts, and fleet management of related equipment. It distributes its products under the Toyota and Lexus brand names in Portugal, Belgium, African countries, Spain, Germany, the United Kingdom, and internationally. The company was incorporated in 1946 and is headquartered in Vila Nova de Gaia, Portugal. Toyota Caetano Portugal, S.A. is a subsidiary of Salvador Caetano Auto (S.G.P.S.), S.A.
PSI ended the session with TOYOTA CAETANO dropping 9.01% to €5.05 on Monday while PSI jumped 1.02% to €6,723.81.
Earnings Per Share
As for profitability, TOYOTA CAETANO has a trailing twelve months EPS of €0.5.
PE Ratio
TOYOTA CAETANO has a trailing twelve months price to earnings ratio of 10.1. Meaning, the purchaser of the share is investing €10.1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.52%.
Yearly Top and Bottom Value
TOYOTA CAETANO’s stock is valued at €5.05 at 22:40 EST, way under its 52-week high of €6.50 and way above its 52-week low of €3.50.
Volume
Today’s last reported volume for TOYOTA CAETANO is 2 which is 98.5% below its average volume of 134.
Moving Average
TOYOTA CAETANO’s worth is under its 50-day moving average of €5.40 and way above its 200-day moving average of €4.43.
More news about TOYOTA CAETANO.
5. BW LPG (BWLPG.OL)
-5.97% Price Change
BW LPG Limited, an investment holding company, engages in ship owning and chartering activities worldwide. The company operates through Shipping and Product Services segments. The company involved in the transportation of liquefied petroleum gas to oil companies, and trading and utility companies. It also offers integrated liquified petroleum gas (LPG) delivery services and support; wholesale and trade of LPG; and management services. It owns and operates LPG vessels and a fleet of very large gas carriers. The company was formerly known as BW Gas LPG Holding Limited and changed its name to BW LPG Limited in September 2013. BW LPG Limited was founded in 1935 and is headquartered in Singapore.
Oslo Børs Benchmark Index_GI ended the session with BW LPG dropping 5.97% to €159.10 on Monday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.4% to €1,448.60, after five successive sessions in a row of gains, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, BW LPG has a trailing twelve months EPS of kr39.13.
PE Ratio
BW LPG has a trailing twelve months price to earnings ratio of 4.07. Meaning, the purchaser of the share is investing kr4.07 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.16%.
Volatility
BW LPG’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.16%, a negative 0.06%, and a positive 2.14%.
BW LPG’s highest amplitude of average volatility was 2.91% (last week), 2.23% (last month), and 2.14% (last quarter).
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 26, 2023, the estimated forward annual dividend rate is 39.9 and the estimated forward annual dividend yield is 33.62%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
BW LPG’s EBITDA is 79.74.
More news about BW LPG.
6. TEKNA HOLDING (TEKNA.OL)
-5.17% Price Change
Tekna Holding ASA engages in the development, manufacture, and sale of micron and nano powders, and plasma process solutions in North America, Europe, Asia, and internationally. The company offers spherical powders, such as titanium, nickel, and aluminum alloys, as well as tungsten and tantalum; and nanopowders, including nickel, silicon, and copper nanopowders, as well as boron nitride nanotubes for use in additive manufacturing, metal injection molding, thermal spray, and hot isostatic pressing. It serves aviation, aerospace, medical, mining and drilling, energy storage, and microelectronics industries. The company was founded in 1990 and is headquartered in Sherbrooke, Canada. Tekna Holding ASA is a subsidiary of Arendals Fossekompani ASA.
Oslo Børs Benchmark Index_GI ended the session with TEKNA HOLDING sliding 5.17% to €5.50 on Monday while Oslo Børs Benchmark Index_GI rose 0.4% to €1,448.60.
Earnings Per Share
As for profitability, TEKNA HOLDING has a trailing twelve months EPS of kr-1.02.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -38.02%.
Yearly Top and Bottom Value
TEKNA HOLDING’s stock is valued at kr5.50 at 22:40 EST, way below its 52-week high of kr10.40 and way above its 52-week low of kr4.40.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TEKNA HOLDING’s stock is considered to be overbought (>=80).
More news about TEKNA HOLDING.
7. ARAMIS GROUP (ARAMI.PA)
-5.09% Price Change
Aramis Group SAS engages in the online sale of used vehicles in France, Belgium, the United Kingdom, Belgium, Austria, Italy, and Spain. It operates under the Aramisauto, Cardoen, Clicars, CarSupermarket, Onlinecars, and Brumbrum brands. The company was founded in 2001 and is based in Arcueil, France. Aramis Group SAS operates as a subsidiary of Stellantis Auto SAS.
CAC 40 ended the session with ARAMIS GROUP dropping 5.09% to €5.22 on Monday, after five sequential sessions in a row of gains. CAC 40 jumped 0.7% to €7,502.01, after four consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, ARAMIS GROUP has a trailing twelve months EPS of €-0.4.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.96%.
More news about ARAMIS GROUP.
8. ABIONYX PHARMA (ABNX.PA)
-5.02% Price Change
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. It develops CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis. The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is based in Balma, France.
CAC 40 ended the session with ABIONYX PHARMA falling 5.02% to €1.29 on Monday, after two successive sessions in a row of losses. CAC 40 rose 0.7% to €7,502.01, after four consecutive sessions in a row of gains, on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, ABIONYX PHARMA has a trailing twelve months EPS of €-0.12.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -46.62%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 4.2%, now sitting on 4.64M for the twelve trailing months.
Volume
Today’s last reported volume for ABIONYX PHARMA is 43495 which is 29.7% below its average volume of 61871.
Volatility
ABIONYX PHARMA’s last week, last month’s, and last quarter’s current intraday variation average was 0.52%, 0.55%, and 2.50%.
ABIONYX PHARMA’s highest amplitude of average volatility was 2.53% (last week), 1.89% (last month), and 2.50% (last quarter).
More news about ABIONYX PHARMA.
9. HYDROGENPRO (HYPRO.OL)
-4.81% Price Change
HydrogenPro ASA engages in designing and delivering hydrogen technology and systems in Norway, Europe, the United States, and the Asia Pacific. It offers high-pressure alkaline electrolyzers. The company serves synthetic aviation fuel, refinery/decarbonization, power to gas, balancing the grid, steel production, fertilizer/ammonia, and shipping markets. HydrogenPro ASA was incorporated in 2013 and is headquartered in Porsgrunn, Norway.
Oslo Børs Benchmark Index_GI ended the session with HYDROGENPRO sliding 4.81% to €9.50 on Monday while Oslo Børs Benchmark Index_GI rose 0.4% to €1,448.60.
Earnings Per Share
As for profitability, HYDROGENPRO has a trailing twelve months EPS of kr-1.48.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.59%.
Yearly Top and Bottom Value
HYDROGENPRO’s stock is valued at kr9.50 at 22:40 EST, way below its 52-week high of kr20.35 and higher than its 52-week low of kr9.10.
Moving Average
HYDROGENPRO’s worth is below its 50-day moving average of kr10.33 and way below its 200-day moving average of kr12.82.
More news about HYDROGENPRO.
10. ADOCIA (ADOC.PA)
-4.55% Price Change
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; and BioChaperone LisPram, a combination of prandial insulin with pramlintide, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and AdoGel Sema for the long-term delivery of therapeutic agents. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.
CAC 40 ended the session with ADOCIA falling 4.55% to €5.67 on Monday, following the last session’s downward trend. CAC 40 jumped 0.7% to €7,502.01, after four consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, ADOCIA has a trailing twelve months EPS of €-1.9.
Moving Average
ADOCIA’s value is way under its 50-day moving average of €7.63 and way below its 200-day moving average of €8.82.
Volatility
ADOCIA’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.82%, a negative 0.24%, and a positive 4.04%.
ADOCIA’s highest amplitude of average volatility was 3.74% (last week), 3.03% (last month), and 4.04% (last quarter).
Yearly Top and Bottom Value
ADOCIA’s stock is valued at €5.67 at 22:40 EST, way under its 52-week high of €16.16 and way higher than its 52-week low of €5.11.
Revenue Growth
Year-on-year quarterly revenue growth declined by 69.1%, now sitting on 6.05M for the twelve trailing months.
More news about ADOCIA.
Stay up to date with our winners and losers daily report
